Brief news reports on Tuberculosis

Floating capsule to help fight TB better

AHMEDABAD: A city-based pharmaceutical research center has developed a capsule using novel floating technology which will allow better absorption of TB drug and thus help people fight TB better.

Read More →

Iran producing high quality TB vaccine

The director of the Pasteur Institute says Iran has succeeded in producing high quality tuberculosis vaccine in a modern way, Iran's Mehr News Agency (MNA) reported.

Read More →

NAM: HATIP newsletter June, 2012

HIV & AIDS treatment in practice (HATIP) is a regular email newsletter for healthcare workers and community-based organisations on HIV treatment in resource-limited settings.

Read More →

World Health Organization sets out route map for scale up of treatment as prevention

WHO is working with countries to identify opportunities for expansion of treatment in line with its 2010 guidelines, which recommended treatment for all people living with HIV with CD4 cell counts below 350, all infants below the age of 2, and for everyone with TB and HIV or hepatitis B and HIV coinfection.

Read More →

Russia: Fight against TB plagued by shortfalls

Russia currently ranks third by the number of multidrug-resistant TB cases worldwide after China and India, countries with vastly larger populations.

Read More →

ACTION produces film on GeneXpert

ACTION has produced a short film to demonstrate the effectiveness of GeneXpert testing in combatting the spread of tuberculosis in resource-limited settings.

Read More →

China changes patent laws to get cheap drugs

In a step that is likely to unnerve global drugmakers, China has overhauled parts of its intellectual property law to allow its domestic pharmaceutical industry to make low-cost versions of medicines under patent protection, Reuters reports. The amended Chinese patent law allows Beijing to issue compulsory licenses to eligible companies to produce generic versions of patented drugs during state emergencies, unusual circumstances or in the public interest.

Read More →

IMI: 215M euros to tackle major research challenges

Europe's Innovative Medicines Initiative (IMI) has launched seven new projects, costing a combined 215 million euros, which will take on some of the biggest challenges in healthcare research.

Read More →

Swazi health minister says new partnerships required to achieve zero TB deaths in the mining sector

Benedict Xaba, Minister of Health of Swaziland, has said that new partnerships must be formed in order to achieve the goals set out in a forthcoming declaration on TB and Mining in Southern Africa.

Read More →

Big Pharma in legal battles for monopoly prices in India

Two large multinational pharmaceutical companies are fighting for patents and monopoly pricing in Indian courts. The outcomes of the cases – involving Novartis and Bayer – are likely to determine the country’s future as a major global supplier of low-cost essential medicines.

Read More →

Page 625 of 691 · Total posts: 10

←First 624 625 626 Last→